BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 35438418)

  • 21. Mean Right Atrial Pressure for Estimation of Left Ventricular Filling Pressure in Patients with Normal Left Ventricular Ejection Fraction: Invasive and Noninvasive Validation.
    Nagueh SF; Smiseth OA; Dokainish H; Andersen OS; Abudiab MM; Schutt RC; Kumar A; Gude E; Sato K; Harb SC; Klein AL
    J Am Soc Echocardiogr; 2018 Jul; 31(7):799-806. PubMed ID: 29580694
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A transcatheter intracardiac shunt device for heart failure with preserved ejection fraction (REDUCE LAP-HF): a multicentre, open-label, single-arm, phase 1 trial.
    Hasenfuß G; Hayward C; Burkhoff D; Silvestry FE; McKenzie S; Gustafsson F; Malek F; Van der Heyden J; Lang I; Petrie MC; Cleland JG; Leon M; Kaye DM;
    Lancet; 2016 Mar; 387(10025):1298-304. PubMed ID: 27025436
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel percutaneous interventional therapies in heart failure with preserved ejection fraction: an integrative review.
    Burlacu A; Simion P; Nistor I; Covic A; Tinica G
    Heart Fail Rev; 2019 Sep; 24(5):793-803. PubMed ID: 30949860
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical study on the treatment of chronic heart failure with a novel D-shant atrium shunt device.
    Shang X; Liu M; Zhong Y; Wang X; Chen S; Fu X; Sun M; Xie M; Ke Y; Guan Y; Zhang C; Dong N
    ESC Heart Fail; 2022 Jun; 9(3):1713-1720. PubMed ID: 35179320
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Atrial shunt device for heart failure with preserved and mildly reduced ejection fraction (REDUCE LAP-HF II): a randomised, multicentre, blinded, sham-controlled trial.
    Shah SJ; Borlaug BA; Chung ES; Cutlip DE; Debonnaire P; Fail PS; Gao Q; Hasenfuß G; Kahwash R; Kaye DM; Litwin SE; Lurz P; Massaro JM; Mohan RC; Ricciardi MJ; Solomon SD; Sverdlov AL; Swarup V; van Veldhuisen DJ; Winkler S; Leon MB;
    Lancet; 2022 Mar; 399(10330):1130-1140. PubMed ID: 35120593
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Echocardiographic Features of Patients With Heart Failure and Preserved Left Ventricular Ejection Fraction.
    Shah AM; Cikes M; Prasad N; Li G; Getchevski S; Claggett B; Rizkala A; Lukashevich I; O'Meara E; Ryan JJ; Shah SJ; Mullens W; Zile MR; Lam CSP; McMurray JJV; Solomon SD;
    J Am Coll Cardiol; 2019 Dec; 74(23):2858-2873. PubMed ID: 31806129
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The sHunt for better breathing in heart failure with preserved ejection fraction.
    Borlaug BA
    Eur J Heart Fail; 2014 Jul; 16(7):709-11. PubMed ID: 24920438
    [No Abstract]   [Full Text] [Related]  

  • 28. Assessment of Predictors of Left Atrial Volume Response to a Transcatheter InterAtrial Shunt Device (from the REDUCE LAP-HF Trial).
    Hanff TC; Kaye DM; Hayward CS; Post MC; Malek F; Hasenfuβ G; Gustafsson F; Burkhoff D; Shah SJ; Litwin SE; Kahwash R; Hummel SL; Borlaug BA; Solomon SD; Lam CSP; Komtebedde J; Silvestry FE;
    Am J Cardiol; 2019 Dec; 124(12):1912-1917. PubMed ID: 31653352
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of device-based therapy options for heart failure with preserved ejection fraction: a simulation study.
    Granegger M; Gross C; Siemer D; Escher A; Sandner S; Schweiger M; Laufer G; Zimpfer D
    Sci Rep; 2022 Apr; 12(1):5761. PubMed ID: 35388023
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Atrial Fibrillation in Heart Failure With Preserved Ejection Fraction: Association With Exercise Capacity, Left Ventricular Filling Pressures, Natriuretic Peptides, and Left Atrial Volume.
    Lam CS; Rienstra M; Tay WT; Liu LC; Hummel YM; van der Meer P; de Boer RA; Van Gelder IC; van Veldhuisen DJ; Voors AA; Hoendermis ES
    JACC Heart Fail; 2017 Feb; 5(2):92-98. PubMed ID: 28017355
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Advances in device-based treatment of heart failure with preserved ejection fraction: evidence from clinical trials.
    Wu Y; Song M; Wu M; Lin L
    ESC Heart Fail; 2024 Feb; 11(1):13-27. PubMed ID: 37986663
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of an interatrial shunt on rest and exercise hemodynamics: results of a computer simulation in heart failure.
    Kaye D; Shah SJ; Borlaug BA; Gustafsson F; Komtebedde J; Kubo S; Magnin C; Maurer MS; Feldman T; Burkhoff D
    J Card Fail; 2014 Mar; 20(3):212-21. PubMed ID: 24487087
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiac Power Output Is Independently and Incrementally Associated With Adverse Outcomes in Heart Failure With Preserved Ejection Fraction.
    Harada T; Yamaguchi M; Omote K; Iwano H; Mizuguchi Y; Amanai S; Yoshida K; Kato T; Kurosawa K; Nagai T; Negishi K; Anzai T; Obokata M
    Circ Cardiovasc Imaging; 2022 Feb; 15(2):e013495. PubMed ID: 35144484
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The haemodynamic basis of lung congestion during exercise in heart failure with preserved ejection fraction.
    Reddy YNV; Obokata M; Wiley B; Koepp KE; Jorgenson CC; Egbe A; Melenovsky V; Carter RE; Borlaug BA
    Eur Heart J; 2019 Dec; 40(45):3721-3730. PubMed ID: 31609443
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and Safety of Inter-Atrial Shunt Devices for Heart Failure With Reduced or Preserved Ejection Fraction: Early Experiences.
    Lu D; Zhu J; Liao B
    Heart Lung Circ; 2018 Mar; 27(3):359-364. PubMed ID: 28483550
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Device-based treatment options for heart failure with preserved ejection fraction.
    Miyagi C; Miyamoto T; Karimov JH; Starling RC; Fukamachi K
    Heart Fail Rev; 2021 Jul; 26(4):749-762. PubMed ID: 33432418
    [TBL] [Abstract][Full Text] [Related]  

  • 37. One-Year Committed Exercise Training Reverses Abnormal Left Ventricular Myocardial Stiffness in Patients With Stage B Heart Failure With Preserved Ejection Fraction.
    Hieda M; Sarma S; Hearon CM; MacNamara JP; Dias KA; Samels M; Palmer D; Livingston S; Morris M; Levine BD
    Circulation; 2021 Sep; 144(12):934-946. PubMed ID: 34543068
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of Baseline Hemodynamics on the Effects of a Transcatheter Interatrial Shunt Device in Heart Failure With Preserved Ejection Fraction.
    Wessler J; Kaye D; Gustafsson F; Petrie MC; Hasenfuβ G; Lam CSP; Borlaug BA; Komtebedde J; Feldman T; Shah SJ; Burkhoff D;
    Circ Heart Fail; 2018 Aug; 11(8):e004540. PubMed ID: 30354556
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mismatch between right- and left-sided filling pressures in heart failure patients with preserved ejection fraction.
    Horiuchi Y; Tanimoto S; Aoki J; Fuse N; Yahagi K; Koseki K; Okuno T; Nakajima H; Hara K; Tanabe K
    Int J Cardiol; 2018 Apr; 257():143-149. PubMed ID: 29506686
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Left atrial decompression through unidirectional left-to-right interatrial shunt for the treatment of left heart failure: first-in-man experience with the V-Wave device.
    Amat-Santos IJ; Bergeron S; Bernier M; Allende R; Barbosa Ribeiro H; Urena M; Pibarot P; Verheye S; Keren G; Yaacoby M; Nitzan Y; Abraham WT; Rodés-Cabau J
    EuroIntervention; 2015 Jan; 10(9):1127-31. PubMed ID: 24832489
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.